PAIN
Volume 114, Issue 1 , Pages 62-70 , March 2005

Characterization of morphine-induced hyperalgesia in male and female rats

Received 28 April 2004 ,Revised 20 October 2004 ,Accepted 22 November 2004.

References 

  1. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid remifentanyl in humans causes hyperalgesia during withdrawal. Pain. 2003;106:49–57
  2. Celerier E, Laulin J-P, Larcher A, Le Moal M, Simonnet G. Evidence for opiate-activated NMDA process masking opiate analgesia in rats. Brain Res. 1999;847:18–25
  3. Celerier E, Rivat C, Jun Y, Laulin J-P, Larcher A, Reynier P, et al. Long-lasting hyperalgesia induced by fentanyl in rats. Anesthesiology. 2000;92:465–472
  4. Celerier E, Laulin J-P, Corecuff J-B, Le Moal M, Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci. 2001;21:4074–4080
  5. Cicero TJ, Nock B, Meyer ER. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther. 1996;279:767–773
  6. Cicero TJ, Nock B, Mayer ER. Sex-related difference in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther. 1997;282:939–944
  7. Compton P, Athanasos P, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J Pain. 2003;4:511–519
  8. Craft RM. Sex differences in drug- and non-drug-induced analgesia. Life Sci. 2003;72:2675–2688
  9. Craft RM. Sex differences in opioid analgesia: “From mouse to man”. Clin J Pain. 2003;19:175–186
  10. Crain SM, Shen K-F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 2001;888:75–82
  11. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941;72:74–79
  12. Dewey WL, Harris LS. Antinociceptive activity of the narcotic antagonist analgesics and antagonistic activity of narcotic analgesics in rodents. J Pharmacol Exp Ther. 1971;179:652–659
  13. Gray WD, Osterberg AC, Scuto TJ. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method. J Pharmacol Exp Ther. 1970;172:154–162
  14. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, et al. Intraoperative remifentanyl increases postoperative pain and morphine requirement. Anesthesiology. 2000;93:409–417
  15. Gutstein HB, Akil H. Opioid analgesics. In:  Hardman JG,  Limbird LE,  Gilman A editor. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001;p. 569–619
  16. Hamann SR, Martin WR. Thermally evoked tail avoidance reflex: input–output relationships and their modulation. Brain Res Bull. 1992;29:507–509
  17. Holtman JR, Jing X, Wala EP. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats. Pharmacol Biochem Behav. 2003;76:285–293
  18. Holtman JR, Sloan JW, Jing X, Wala EP. Modification of morphine analgesia and tolerance by flumazenil in male and female rats. Eur J Pharmacol. 2003;470:149–156
  19. Holtman JR, Sloan JW, Wala EP. Morphine tolerance in male and female rats. Pharmacol Biochem Behav. 2004;77:517–523
  20. Kest B, Sarton E, Dahan A. Gender differences in opioid-mediated analgesia. Anesthesiology. 2000;93:539–547
  21. Koppert W, Angst M, Alsheimer M, Sittl R, Albrecht S, Schuttler J, et al. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanyl in humans. Pain. 2003;106:91–99
  22. Larcher A, Laulin JP, Celerier E, Le Moal M, Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-d-aspartate-dependent pain facilitatory systems. Neuroscience. 1998;84:583–589
  23. Laulin J-P, Larcher A, Celerier E, Le Moal M, Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci. 1998;10:782–785
  24. Laulin JP, Celerier E, Larcher A, Le Moal M, Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience. 1999;89:631–636
  25. Laulin J-P, Maurette P, Corcuff J-B, Rivat C, Chauvin M, Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg. 2002;94:1263–1269
  26. Luginbuhl M, Gerber A, Schnider TW, Peterson-Felix S, Arendt-Nielsen L, Curatolo M. Modulation of remifentanyl-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg. 2003;96:726–732
  27. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Rev. 1999;30:289–304
  28. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002;100:213–217
  29. Miasakowski C, Gear RW, Levine JD. Sex-related differences in analgesic responses. In:  Fillingim RB editors. Sex, gender, and pain. Progress in pain research and management. vol. 17:Seattle: IASP Press; 2000;p. 209–230
  30. Nemmani KV, Grisel JE, Stowe JR, Smith-Carliss R, Mogil JS. Modulation of morphine analgesia by site-specific N-methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain. 2004;109:274–283
  31. O'Callaghan JP, Holtzman SG. Quantification of the analgesic avctivity of narcotics analgesics by a modified hot-plate procedure. J Pharmacol Exp Ther. 1975;192:497–505
  32. Parvini S, Hamann SR, Martin WR. Pharmacologic characteristics of a medullary hyperalgesic center. J Pharmacol Exp Ther. 1993;265:286–293
  33. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957;111:409–419
  34. Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain?. Neuro Report. 2003;14:1–7
  35. Vanderah TW, Ossipov MH, Lai J, Malan TP, Porreca F. Mechanism of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain. 2001;92:5–9
  36. Woolfe G, MacDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 1944;80:300–307

PII: S0304-3959(04)00551-2

doi: 10.1016/j.pain.2004.11.014

PAIN
Volume 114, Issue 1 , Pages 62-70 , March 2005